اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدA feasible roadmap to identifying significant intercellular genomic heterogeneity in deep sequencing data
178
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Intercellular heterogeneity serves as both a confounding factor in studying individual clones and an information source in characterizing any heterogeneous tissues, such as blood, tumor systems. Due to inevitable sequencing errors and other sample preparation artifacts such as PCR errors, systematic efforts to characterize intercellular genomic heterogeneity must effectively distinguish genuine clonal sequences from fake derivatives. We developed a novel approach (SIGH) for identifying significant genuine clonal sequences directly from mixed sequencing reads that can improve genomic analyses in many biological contexts. This method offers several attractive features: (1) it automatically estimates the error rate from raw sequence reads and identifies genuine clonal sequences; (2) it is robust to the large variety of error rate due to the various experimental conditions; (3) it is supported by a well grounded statistical framework that exploits probabilistic characteristics of sequencing errors; (4) its unbiased strategy allows detecting rare clone(s) despite that clone relative abundance; and (5) it estimates constituent proportions in each sample. Extensive realistic simulation studies show that our method can reliably estimate the error rates and faithfully distinguish the genuine clones from fake derivatives, paving the way for follow up analysis that is otherwise ruined by the often dominant fake clones.
قيم البحث
اقرأ أيضاً
We present a nonparametric Bayesian method for disease subtype discovery in multi-dimensional cancer data. Our method can simultaneously analyse a wide range of data types, allowing for both agreement and disagreement between their underlying cluster
ing structure. It includes feature selection and infers the most likely number of disease subtypes, given the data. We apply the method to 277 glioblastoma samples from The Cancer Genome Atlas, for which there are gene expression, copy number variation, methylation and microRNA data. We identify 8 distinct consensus subtypes and study their prognostic value for death, new tumour events, progression and recurrence. The consensus subtypes are prognostic of tumour recurrence (log-rank p-value of $3.6 times 10^{-4}$ after correction for multiple hypothesis tests). This is driven principally by the methylation data (log-rank p-value of $2.0 times 10^{-3}$) but the effect is strengthened by the other 3 data types, demonstrating the value of integrating multiple data types. Of particular note is a subtype of 47 patients characterised by very low levels of methylation. This subtype has very low rates of tumour recurrence and no new events in 10 years of follow up. We also identify a small gene expression subtype of 6 patients that shows particularly poor survival outcomes. Additionally, we note a consensus subtype that showly a highly distinctive data signature and suggest that it is therefore a biologically distinct subtype of glioblastoma. The code is available from https://sites.google.com/site/multipledatafusion/
Motivation: Bisulphite sequencing enables the detection of cytosine methylation. The sequence of the methylation states of cytosines on any given read forms a methylation pattern that carries substantially more information than merely studying the av
erage methylation level at individual positions. In order to understand better the complexity of DNA methylation landscapes in biological samples, it is important to study the diversity of these methylation patterns. However, the accurate quantification of methylation patterns is subject to sequencing errors and spurious signals due to incomplete bisulphite conversion of cytosines. Results: A statistical model is developed which accounts for the distribution of DNA methylation patterns at any given locus. The model incorporates the effects of sequencing errors and spurious reads, and enables estimation of the true underlying distribution of methylation patterns. Conclusions: Calculation of the estimated distribution over methylation patterns is implemented in the R Bioconductor package MPFE. Source code and documentation of the package are also available for download at http://bioconductor.org/packages/3.0/bioc/html/MPFE.html.
The availability of genomic data is often essential to progress in biomedical research, personalized medicine, drug development, etc. However, its extreme sensitivity makes it problematic, if not outright impossible, to publish or share it. As a resu
lt, several initiatives have been launched to experiment with synthetic genomic data, e.g., using generative models to learn the underlying distribution of the real data and generate artificial datasets that preserve its salient characteristics without exposing it. This paper provides the first evaluation of the utility and the privacy protection of six state-of-the-art models for generating synthetic genomic data. We assess the performance of the synthetic data on several common tasks, such as allele population statistics and linkage disequilibrium. We then measure privacy through the lens of membership inference attacks, i.e., inferring whether a record was part of the training data. Our experiments show that no single approach to generate synthetic genomic data yields both high utility and strong privacy across the board. Also, the size and nature of the training dataset matter. Moreover, while some combinations of datasets and models produce synthetic data with distributions close to the real data, there often are target data points that are vulnerable to membership inference. Looking forward, our techniques can be used by practitioners to assess the risks of deploying synthetic genomic data in the wild and serve as a benchmark for future work.
The accurate prediction of biological features from genomic data is paramount for precision medicine, sustainable agriculture and climate change research. For decades, neural network models have been widely popular in fields like computer vision, ast
rophysics and targeted marketing given their prediction accuracy and their robust performance under big data settings. Yet neural network models have not made a successful transition into the medical and biological world due to the ubiquitous characteristics of biological data such as modest sample sizes, sparsity, and extreme heterogeneity. Results: Here, we investigate the robustness, generalization potential and prediction accuracy of widely used convolutional neural network and natural language processing models with a variety of heterogeneous genomic datasets. While the perspective of a robust out-of-the-box neural network model is out of reach, we identify certain model characteristics that translate well across datasets and could serve as a baseline model for translational researchers. Here, we investigate the robustness, generalization potential and prediction accuracy of widely used convolutional neural network and natural language processing models with a variety of heterogeneous genomic datasets. While the perspective of a robust out-of-the-box neural network model is out of reach, we identify certain model characteristics that translate well across datasets and could serve as a baseline model for translational researchers.
Motivation: As cancer researchers have come to appreciate the importance of intratumor heterogeneity, much attention has focused on the challenges of accurately profiling heterogeneity in individual patients. Experimental technologies for directly pr
ofiling genomes of single cells are rapidly improving, but they are still impractical for large-scale sampling. Bulk genomic assays remain the standard for population-scale studies, but conflate the influences of mixtures of genetically distinct tumor, stromal, and infiltrating immune cells. Many computational approaches have been developed to deconvolute these mixed samples and reconstruct the genomics of genetically homogeneous clonal subpopulations. All such methods, however, are limited to reconstructing only coarse approximations to a few major subpopulations. In prior work, we showed that one can improve deconvolution of genomic data by leveraging substructure in cellular mixtures through a strategy called simplicial complex inference. This strategy, however, is also limited by the difficulty of inferring mixture structure from sparse, noisy assays. Results: We improve on past work by introducing enhancements to automate learning of substructured genomic mixtures, with specific emphasis on genome-wide copy number variation (CNV) data. We introduce methods for dimensionality estimation to better decompose mixture model substructure; fuzzy clustering to better identify substructure in sparse, noisy data; and automated model inference methods for other key model parameters. We show that these improvements lead to more accurate inference of cell populations and mixture proportions in simulated scenarios. We further demonstrate their effectiveness in identifying mixture substructure in real tumor CNV data. Availability: Source code is available at http://www.cs.cmu.edu/~russells/software/WSCUnmix.zip
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
